Transcriptomic and Long-Term Behavioral Deficits Associated with Developmental 3.5 GHz Radiofrequency Radiation Exposures in Zebrafish.
Journal
Environmental science & technology letters
ISSN: 2328-8930
Titre abrégé: Environ Sci Technol Lett
Pays: United States
ID NLM: 101628367
Informations de publication
Date de publication:
12 Apr 2022
12 Apr 2022
Historique:
received:
13
01
2022
revised:
10
02
2022
accepted:
11
02
2022
entrez:
18
4
2022
pubmed:
19
4
2022
medline:
19
4
2022
Statut:
ppublish
Résumé
The rapid deployment of the fifth-generation (5G) spectrum by the telecommunication industry is intended to promote better connectivity and data integration among various industries. However, concerns among the public about the safety and health effects of radiofrequency radiations (RFRs) emitted from the newer-generation cell phone frequencies remain, partly due to the lack of robust scientific data. Previously, we used developmental zebrafish to model the bioactivity of 3.5 GHz RFR, a frequency used by 5G-enabled cell phones, in a novel RFR exposure chamber. With RFR exposures from 6 h post-fertilization (hpf) to 48 hpf, we observed that, despite no teratogenic effects, embryos showed subtle hypoactivity in a startle response behavior assay, suggesting abnormal sensorimotor behavior. This study builds upon the previous one by investigating the transcriptomic basis of RFR-associated behavior effects and their persistence into adulthood. Using mRNA sequencing, we found a modest transcriptomic disruption at 48 hpf, with 28 differentially expressed genes. KEGG pathway analysis showed that biochemical pathways related to metabolism were significantly perturbed. Embryos were grown to adulthood, and then a battery of behavioral assays suggested subtle but significant abnormal responses in RFR-exposed fish across the different assays evaluated that suggest potential long-term behavioral effects. Overall, our study suggests the impacts of RFRs on the developing brain, behavior, and the metabolome should be further explored.
Identifiants
pubmed: 35434172
doi: 10.1021/acs.estlett.2c00037
pmc: PMC9009179
doi:
Types de publication
Journal Article
Langues
eng
Pagination
327-332Informations de copyright
© 2022 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Front Cell Dev Biol. 2021 Apr 09;9:663032
pubmed: 33898466
Front Genet. 2019 May 03;10:260
pubmed: 31130979
Metab Brain Dis. 2018 Jun;33(3):753-763
pubmed: 29332300
PLoS One. 2020 Jul 9;15(7):e0235869
pubmed: 32645106
J Radiat Res. 2020 Mar 23;61(2):197-206
pubmed: 31927574
Dev Dyn. 1995 Jul;203(3):253-310
pubmed: 8589427
Br J Soc Psychol. 2020 Jul;59(3):628-640
pubmed: 32564418
PLoS One. 2020 Dec 31;15(12):e0240070
pubmed: 33382700
Hum Mol Genet. 2014 Aug 1;23(15):4103-10
pubmed: 24647604
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Pharmacol Ther. 2016 May;161:11-21
pubmed: 27016469
Proc Natl Acad Sci U S A. 2021 Aug 3;118(31):
pubmed: 34330835
Sci Rep. 2014 May 29;4:5103
pubmed: 24869783
Toxicology. 2007 Jun 25;235(3):167-75
pubmed: 17449163